life-threatening cold. we re tracking it all. also tonight, the january 6th committee s final report recommending donald trump be barred from holding office ever again. how the former president is responding. the new numbers from the cdc. will the holidays lead to another spike? the crash caught on camera. a plane slamming into the beach in santa monica. the warning from fedex and u.p.s. for last-minute shoppers. will your holiday packages arrive on time? and celebrating christmas in wartime. st. nick bringing holiday cheer to children in ukraine. announcer: this is nbc nightly news with lester holt. and a good friday evening to you. i m craig melvin in for lester. for many tonight, mother nature has decided to be quite the grinch. this is going to be the coldest, wettest, snowiest holiday in recent memory thanks to a once in a generation massive winter storm that s disrupting plans for millions. for some it s the really strong wind gusts already knocking out
Children's National Hospital taps Clearway to deliver $2.8M gene therapy beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.
bluebird bio, Inc. (NASDAQ:BLUE) Q3 2023 Earnings Call Transcript November 7, 2023 bluebird bio, Inc. beats earnings expectations. Reported EPS is $-0.66, expectations were $-0.69. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the bluebird bio Third Quarter 2023 Results Conference Call. At this time, all participants are in […]
in my mind landing on the moon. we opened up the potential for so much more. reporter: zynteglo is a gene therapy that modifies their own blood stem cells to eliminate the need for transfusions. it s a one time only procedure with an out of this world price tag, $2.8 million. who should pay for the $2.8 million bill? it s my hope that insurers will jump on board. reporter: at this point it s unclear if the barrons insurer would cover the cost and it s not even the most expensive fda gene approved therapy. dr. david rind is with the price watchdog icer. if you use cost effective analysis, you come to a conclusion that 2.8 million is probably just a little bit beyond the top end of the price range for zynteglo. a more fair price would be $2.1 million. this is absolutely a game changer, anne.